Skip to main content

Podophyllotoxin (International)



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Dermatological agent

Topical antimitotic agent

Topical cytostatic agent

Chemical Name

Furo[3',4':6,7]naphto[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimetoxyphenyl)-, [5R-(5α,5aβ,8aα,9α)]-

Foreign Names

  • Podophyllotoxinum (Latin)
  • Podophyllotoxin (German)
  • Podophyllotoxine (French)

Generic Names

  • Podofilox (OS: USAN)
  • Podophyllotoxin (OS: BAN)
  • Podophyllotoxine (OS: DCF)
  • Podophyllotoxin (PH: Ph. Helv. 11)

Brand Names

  • Condilom
    Bussié, Colombia; Bussié, Honduras
  • Condiver
    Lacico, Colombia
  • Condylin
    Takeda Austria, Bulgaria
  • Condyline
    2care4, Norway; Astellas, Italy; Astellas, Kuwait; BModesto, Netherlands; Famar, Georgia; Galderma, Norway; Galderma Nordic, Denmark; Galderma Nordic, Sweden; Galderma Nordic AB, Finland; Galderma Nordic AB, Iceland; LEO Pharma, Netherlands; LEO Pharma, New Zealand; LEO Pharma, Poland; LEO Pharma, Romania; Medcor Pharmaceuticals, Netherlands; Orifarm, Norway; Sanofi-Aventis, Canada; Takeda, Australia; Takeda, Ireland; Takeda Pharma, Switzerland; Takeda UK, United Kingdom
  • Condyline 0.5%
    LEO Pharma, France
  • Condyline 5 mg/ml
    Takeda, Hungary
  • Condylox
    Allergan, United States; Dr. August Wolff, Germany; Takeda, Israel; Tianjin Takeda Pharmaceutical, China
  • Condylox 0.5%
    Takeda Pharma, Austria
  • Podofilm
    Assos, Turkey; Paladin, Canada; Pharmascience, Hong Kong
  • Podofilox
    Paddock Laboratories, United States
  • Podox 0.5%
    Bussié, Colombia; Bussié, Dominican Republic; Bussié, Guatemala; Bussié, Honduras
  • Podoxin
    Cassara, Argentina; Promofarma, Uruguay
  • Posalfilin [+ Salicylic acid]
    Norgine, New Zealand
  • Wartec
    BModesto, Netherlands; Dr. Fisher Farma, Netherlands; Euro Registratie, Netherlands; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Sweden; GlaxoSmithKline A.B.E.E., Greece; GlaxoSmithKline Australia, Australia; GSK, Czech Republic; Medcor Pharmaceuticals, Netherlands; Phoenix Labs, Netherlands; Stiefel, Brazil; Stiefel, China; Stiefel, Estonia; Stiefel, Spain; Stiefel, Hong Kong; Stiefel, Italy; Stiefel, Lebanon; Stiefel, Mexico; Stiefel, Oman; Stiefel, Romania; Stiefel, Slovakia; Stiefel, Taiwan; Stiefel, South Africa; Stiefel Laboratories Polska Sp. z.o.o., Poland
  • Wartec 0.15%
    GlaxoSmithKline, Germany; GlaxoSmithKline, Finland; GlaxoSmithKline A.B.E.E., Greece; Stiefel, Germany
  • Wartec 0.5%
    GlaxoSmithKline A.B.E.E., Greece
  • Warticon
    Stiefel, United Kingdom; Stiefel, Ireland
  • Warticon 0.5%
    GlaxoSmithKline, Cyprus
  • You Tuo Xin
    Huawei Pharmaceutical, China


BANBritish Approved Name
DCFDénomination Commune Française
OSOfficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.